World Patient Engagement Solutions Market by Component - Opportunities and Forecasts, 2020-2027
|
A00768
|
Pages: NA
|
May 2020 |
2325 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Patient engagement refers to anything that enables healthcare institutions to establish communication with their patients to using patient portal online. However, patient engagement is not just about engaging technology such as portal as well as automated messaging. Besides this, the process plays a vital role in ensuring patient satisfaction. On the other hand, the technology improves the service quality and ensures safety.
There are many drivers, restraints and opportunities that are influencing the patient engagement solutions market. Increasing awareness about mobile health, growing aging population as well as incentives provided by the government are responsible for driving the patient engagement market. However, absence of health literacy has hampered the market growth to a greater extent. Moreover, demand for value based drugs due to an increase in peer pressure and dramatic shift in patient specific solution would create greater opportunities.
The market is segmented based on components, delivery model, therapeutics, end-customer and geography. The key components assessed in the study includes hardware, software, consulting services and many more. Delivery model covered during the study are on premise, cloud and web. Therapeutics areas discussed in the report consists of fitness, diabetes, women health, obesity etc. Major end-customers of the market are payers, providers, patients and more. Regions such as North America, Europe, Asia -Pacific and LAMEA would experience rapid growth.
A closer look at the competitive landscape reveals that major IT brands are busy launching patient engagement solutions and generating clients in the same month itself. Prominent market players are also seen acquiring new companies or local market players to maintain their competitive edge. Other business strategies favored by the companies include constant upgradation, joint ventures and collaborations. Prominent brands active in the market are Orion Health, Emmi Solutions LLC., Allscripts Inc., Medecision Inc., Athenahealth, Inc. and others.
KEY BENEFITS FOR STAKEHOLDERS
- The market research report provides an integrated information on the major drivers, restraints and opportunities influencing the industry growth during the forecast period.
- The study further drills down to produce data volume by components, end customers and demography.
- SWOT analysis of major brands, highlights weaknesses, strengths, opportunities and threats. The data proves effective for business owners planning on designing their marketing and branding strategies.
- Region wise business performance discussed in the market research report would be valuable for enterprises planning to explore new areas.
- The report not only examines the market dynamics but also takes a closer look at the growth rate and industrial chain structure.
- Study further weigh up on the prominent market players and their business strategies to maintain their position.
- Assessment of upstream and downstream market also forms an important part of the report.
PATIENT ENGAGEMENT SOLUTION MARKET KEY SEGMENTS
Patient Engagement Solutions Market By Component
- Hardware
- Software
- Consulting Services
- Others
Patient Engagement Solutions Market By Delivery Model
- On -Premise
- Web
- Cloud
Patient Engagement Solutions Market By Therapeutics
- Fitness,
- Diabetes
- Women Health
- Obesity
- Others
Patient Engagement Solutions Market By End Customers
- Healthcare Providers
- Patients
- Payers
- Others
Patient Engagement Solutions Market Geography
- North America
- Europe
- Asia -Pacific
- LAMEA
- Key Market Players
- Orion Health
- Emmi Solutions LLC.
- Allscripts Inc.
- Medecision Inc.
- Athenahealth, Inc.
1. INTRODUCTION
1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tool & model
2. EXECUTIVE SUMMARY
2.1. CXO perspective
3. MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top factors impacting the market
3.2.2. Top investment pockets
3.2.3. Top winning strategies
3.3. Regulatory initiatives
3.4. Porter’s five force analysis
3.5. Market player positioning
3.6. Market dynamics
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities
4. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2017-2024 ($MILLION)
4.1. Market overview
4.2. Hardware
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. Software
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. Services
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
5. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2017-2024 ($MILLION)
5.1. Market overview
5.2. On-premise
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. Cloud
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
6. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2017-2024 ($MILLION)
6.1. Market overview
6.2. Hospitals and healthcare providers
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.3. Healthcare payers
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.4. Individual users
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.5. Others
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
7. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2017-2024 ($MILLION)
7.1. Market overview
7.2. Health management
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.3. Home health management
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.4. Financial health management
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.5. Social and behavioral management
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.6. Others
7.6.1. Key market trends
7.6.2. Key growth factors and opportunities
7.6.3. Market size and forecast
8. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2017-2024 ($MILLION)
8.1. Market overview
8.2. Chronic diseases
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.3. Women’s health
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.4. Fitness
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.5. Others
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
9. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2017-2024 ($MILLION)
9.1. Market overview
9.2. North America
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast by
9.2.3.1. Component
9.2.3.2. Deployment mode
9.2.3.3. End user
9.2.3.4. Application
9.2.3.5. Therapeutic area
9.2.3.6. Country
9.2.3.6.1. U.S.
9.2.3.6.1.1. Market size and forecast, by component
9.2.3.6.1.2. Market size and forecast, by deployment mode
9.2.3.6.1.3. Market size and forecast, by end user
9.2.3.6.1.4. Market size and forecast, by application
9.2.3.6.1.5. Market size and forecast, by therapeutic area
9.2.3.6.2. Canada
9.2.3.6.2.1. Market size and forecast, by component
9.2.3.6.2.2. Market size and forecast, by deployment mode
9.2.3.6.2.3. Market size and forecast, by end user
9.2.3.6.2.4. Market size and forecast, by application
9.2.3.6.2.5. Market size and forecast, by therapeutic area
9.2.3.6.3. Mexico
9.2.3.6.3.1. Market size and forecast, by component
9.2.3.6.3.2. Market size and forecast, by deployment mode
9.2.3.6.3.3. Market size and forecast, by end user
9.2.3.6.3.4. Market size and forecast, by application
9.2.3.6.3.5. Market size and forecast, by therapeutic area
9.3. Europe
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast by
9.3.3.1. Component
9.3.3.2. Deployment mode
9.3.3.3. End user
9.3.3.4. Application
9.3.3.5. Therapeutic area
9.3.3.6. Country
9.3.3.6.1. UK
9.3.3.6.1.1. Market size and forecast, by component
9.3.3.6.1.2. Market size and forecast, by deployment mode
9.3.3.6.1.3. Market size and forecast, by end user
9.3.3.6.1.4. Market size and forecast, by application
9.3.3.6.1.5. Market size and forecast, by therapeutic area
9.3.3.6.2. Germany
9.3.3.6.2.1. Market size and forecast, by component
9.3.3.6.2.2. Market size and forecast, by deployment mode
9.3.3.6.2.3. Market size and forecast, by end user
9.3.3.6.2.4. Market size and forecast, by application
9.3.3.6.2.5. Market size and forecast, by therapeutic area
9.3.3.6.3. France
9.3.3.6.3.1. Market size and forecast, by component
9.3.3.6.3.2. Market size and forecast, by deployment mode
9.3.3.6.3.3. Market size and forecast, by end user
9.3.3.6.3.4. Market size and forecast, by application
9.3.3.6.3.5. Market size and forecast, by therapeutic area
9.3.3.6.4. Rest of Europe
9.3.3.6.4.1. Market size and forecast, by component
9.3.3.6.4.2. Market size and forecast, by deployment mode
9.3.3.6.4.3. Market size and forecast, by end user
9.3.3.6.4.4. Market size and forecast, by application
9.3.3.6.4.5. Market size and forecast, by therapeutic area
9.4. Asia-Pacific
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast by
9.4.3.1. Component
9.4.3.2. Deployment mode
9.4.3.3. End user
9.4.3.4. Application
9.4.3.5. Therapeutic area
9.4.3.6. Country
9.4.3.6.1. China
9.4.3.6.1.1. Market size and forecast, by component
9.4.3.6.1.2. Market size and forecast, by deployment mode
9.4.3.6.1.3. Market size and forecast, by end user
9.4.3.6.1.4. Market size and forecast, by application
9.4.3.6.1.5. Market size and forecast, by therapeutic area
9.4.3.6.2. India
9.4.3.6.2.1. Market size and forecast, by component
9.4.3.6.2.2. Market size and forecast, by deployment mode
9.4.3.6.2.3. Market size and forecast, by end user
9.4.3.6.2.4. Market size and forecast, by application
9.4.3.6.2.5. Market size and forecast, by therapeutic area
9.4.3.6.3. Japan
9.4.3.6.3.1. Market size and forecast, by component
9.4.3.6.3.2. Market size and forecast, by deployment mode
9.4.3.6.3.3. Market size and forecast, by end user
9.4.3.6.3.4. Market size and forecast, by application
9.4.3.6.3.5. Market size and forecast, by therapeutic area
9.4.3.6.4. Rest of Asia-Pacific
9.4.3.6.4.1. Market size and forecast, by component
9.4.3.6.4.2. Market size and forecast, by deployment mode
9.4.3.6.4.3. Market size and forecast, by end user
9.4.3.6.4.4. Market size and forecast, by application
9.4.3.6.4.5. Market size and forecast, by therapeutic area
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast by
9.5.3.1. Component
9.5.3.2. Deployment mode
9.5.3.3. End user
9.5.3.4. Application
9.5.3.5. Therapeutic area
9.5.3.6. Country
9.5.3.6.1. Latin America
9.5.3.6.1.1. Market size and forecast, by component
9.5.3.6.1.2. Market size and forecast, by deployment mode
9.5.3.6.1.3. Market size and forecast, by end user
9.5.3.6.1.4. Market size and forecast, by application
9.5.3.6.1.5. Market size and forecast, by therapeutic area
9.5.3.6.2. Middle East
9.5.3.6.2.1. Market size and forecast, by component
9.5.3.6.2.2. Market size and forecast, by deployment mode
9.5.3.6.2.3. Market size and forecast, by end user
9.5.3.6.2.4. Market size and forecast, by application
9.5.3.6.2.5. Market size and forecast, by therapeutic area
9.5.3.6.3. Africa
9.5.3.6.3.1. Market size and forecast, by component
9.5.3.6.3.2. Market size and forecast, by deployment mode
9.5.3.6.3.3. Market size and forecast, by end user
9.5.3.6.3.4. Market size and forecast, by application
9.5.3.6.3.5. Market size and forecast, by therapeutic area
10. COMPANY PROFILES
10.1. Cisco Systems, Inc.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Business performance
10.1.4. Operating business segments
10.1.5. Key strategies and developments
10.2. Mckesson Corporation
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Business performance
10.2.4. Operating business segments
10.2.5. Key strategies and developments
10.3. Welvu, Inc.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Business performance
10.3.4. Operating business segments
10.3.5. Key strategies and developments
10.4. Get Real Health
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Business performance
10.4.4. Operating business segments
10.4.5. Key strategies and developments
10.5. EMMI Solutions, LLC
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Business performance
10.5.4. Operating business segments
10.5.5. Key strategies and developments
10.6. GetWellNetwork Inc
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Business performance
10.6.4. Operating business segments
10.6.5. Key strategies and developments
10.7. Phytel, Inc.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Business performance
10.7.4. Operating business segments
10.7.5. Key strategies and developments
10.8. Mckesson Corporation
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Business performance
10.8.4. Operating business segments
10.8.5. Key strategies and developments
10.9. Allscripts Healthcare Solutions
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Business performance
10.9.4. Operating business segments
10.9.5. Key strategies and developments
10.10. Athenahealth, Inc.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Business performance
10.10.4. Operating business segments
10.10.5. Key strategies and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Patient Engagement Solutions Market-
Opportunities and Forecasts, 2020-2027
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5,370$4,833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.